| Product Code: ETC9684310 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Industry Life Cycle |
3.4 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Porter's Five Forces |
3.5 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of exocrine pancreatic insufficiency (EPI) in Thailand |
4.2.2 Growing prevalence of diseases such as cystic fibrosis and chronic pancreatitis leading to EPI |
4.2.3 Advancements in therapeutic options for EPI in the Thai market |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and access in certain regions of Thailand |
4.3.2 High cost associated with EPI therapeutics and diagnostics |
4.3.3 Regulatory challenges in the approval process for new EPI treatments in Thailand |
5 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Trends |
6 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Types |
6.1 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.1.4 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Pancreatic Function Test, 2021- 2031F |
6.2 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Nutritional Management, 2021- 2031F |
6.2.3 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Pancreatic Enzyme Replacement Therapy, 2021- 2031F |
6.3 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Generic, 2021- 2031F |
6.3.3 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Branded, 2021- 2031F |
6.4 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.6 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Research and Academic Institute, 2021- 2031F |
6.4.7 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Import-Export Trade Statistics |
7.1 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Export to Major Countries |
7.2 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Imports from Major Countries |
8 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Key Performance Indicators |
8.1 Number of EPI diagnoses in Thailand |
8.2 Adoption rate of new EPI therapeutics and diagnostics in the market |
8.3 Patient satisfaction and adherence rates with EPI treatments |
8.4 Number of healthcare facilities offering EPI diagnosis and treatment services |
8.5 Research and development investment in EPI therapies in Thailand |
9 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Opportunity Assessment |
9.1 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Competitive Landscape |
10.1 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Thailand Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here